These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6865682)

  • 1. [Method of gamma teletherapy in prostatic cancer].
    Aliev BM; Tkachev SI; Filippiuk VV
    Med Radiol (Mosk); 1983 Jun; 28(6):25-30. PubMed ID: 6865682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of rotational gamma teletherapy of prostatic cancer].
    Starichkov MS; Tkachev SI
    Vopr Onkol; 1982; 28(11):73-6. PubMed ID: 7147836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of gamma teletherapy of prostate cancer patients].
    Sviridova TV; Dunchik VN; Mardynskiĭ IuS; Tsodikova LB
    Med Radiol (Mosk); 1983 Nov; 28(11):15-20. PubMed ID: 6645824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Planning combined radiation therapy of rectal cancer taking into account the biological effect of the radiation].
    Gontsa AA; Simbirtseva LP; Dianina ES
    Med Radiol (Mosk); 1985 Oct; 30(10):23-30. PubMed ID: 4058275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of the field length in planning radioisotope teletherapy].
    Kokontsev AA
    Med Radiol (Mosk); 1988 Sep; 33(9):13-6. PubMed ID: 3419293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Formation of dose fields in local irradiation of cancer of the prostate].
    Ratner TG; Makarova GV; Klepper LIa; Tarakanova IV; Dolgikh AP
    Med Radiol (Mosk); 1988 Apr; 33(4):63-8. PubMed ID: 3357396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the effectiveness of preoperative radiation and thermoradiation therapy in treating breast cancer].
    Muravskaia GV; Pantiushenko TA; Fradkin SZ; Zhabrid EA; Moiseenko VV
    Med Radiol (Mosk); 1984 Apr; 29(4):50-5. PubMed ID: 6717267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
    Wang-Chesebro A; Xia P; Coleman J; Akazawa C; Roach M
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):654-62. PubMed ID: 17011444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiation therapy with local UHF hyperthermia in the late stages of laryngeal cancer].
    Tsyganov AI; Rozenfel'd LG; Bykov VL; Martyniuk LA; Opanashchenko GA
    Med Radiol (Mosk); 1985 Aug; 30(8):18-21. PubMed ID: 4033384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radiation and chemoradiation therapy of malignant laryngopharyngeal tumors].
    Morozov AI; Rogachikova TA; Korshunov AI; Biriukov VA; Pinskaia LG
    Med Radiol (Mosk); 1985 Aug; 30(8):15-8. PubMed ID: 4033383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.
    Michalski JM; Winter K; Purdy JA; Perez CA; Ryu JK; Parliament MB; Valicenti RK; Roach M; Sandler HM; Markoe AM; Cox JD
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):735-42. PubMed ID: 14967428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer.
    Fonteyne V; De Gersem W; De Neve W; Jacobs F; Lumen N; Vandecasteele K; Villeirs G; De Meerleer G
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1013-20. PubMed ID: 19386427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical trial of a variation of combined radiation therapy of recurrent rectal cancer in women].
    Aliev BM; Akhmedshina AN
    Vopr Onkol; 1981; 27(1):44-8. PubMed ID: 6256974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined treatment of malignant kidney tumors].
    Barkanov AI; Goldobenko GV; Matveev VP; Figurin KM
    Med Radiol (Mosk); 1988 Jun; 33(6):54-7. PubMed ID: 2838718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of time-dose-fractionation models in planning the radiation treatment of malignant tumors].
    Pavlov AS; Kostromina KN; Datsenko VS; Fadeeva MA; Bocharov AL
    Med Radiol (Mosk); 1983 Mar; 28(3):80-3. PubMed ID: 6835063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiation therapy in the combined treatment of prostatic cancer patients].
    Aliev BM; Matveev BP; Tkachev SI
    Urol Nefrol (Mosk); 1986; (6):37-41. PubMed ID: 3811072
    [No Abstract]   [Full Text] [Related]  

  • 19. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
    Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
    Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of prostate dose escalation in patients with greater than 15% risk of pelvic lymph node involvement.
    Jacob R; Hanlon AL; Horwitz EM; Movsas B; Uzzo RG; Pollack A
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):695-701. PubMed ID: 15708247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.